Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-060581

Chief Commercial Officer sold 382 shares at $15.79 ($6,032)

From the SEC's structured data for this filing

Trades in this filing

Wettig Thane · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-08 Sale : show line 1 in the form −382 $15.79 $6,032 89,897 D
Open-market sales · 382 sh · avg $15.79 · $6,032
Loading xslF345X03/doc4.xml…